Key Takeaways HWC shares hit a 52-week high of $67.10, gaining 23.2% over six months and beating the industry.Hancock Whitney's revenues saw a 3.5% CAGR over five years, supported by expansion plans and loan growth.HWC's expanding NIM, solid balance sheet, dividend hikes and new buyback plan support shareholder value.Shares of Hancock Whitney Corp. (HWC) touched a new 52-week high of $67.10 per share in yesterday’s trading session to finally close at $66.05. Over the last six months, the HWC stock has gaine ...

Fabrice COFFRINI / AFP via Getty Images UBS gave its highest conviction calls for 2026, laying out its top stock picks across sectors. The bank is bullish on a wide variety of companies spanning several high-growth sectors. A few of its top stocks for 2026 include Acadia Pharmaceuticals and Alliant Energy. If you're making your list of stocks to watch in the new year, UBS has a list of its highest conviction stocks for 2026 that could offer some insight. The bank released its list of top picks fo ...

We came across a bearish thesis on Capricor Therapeutics, Inc. on Alpha Talon Investment Research’s Substack by AT Investment Research. In this article, we will summarize the bulls’ thesis on CAPR. Capricor Therapeutics, Inc.'s share was trading at $26.55 as of December 15th. Telix Pharma (TLX) Makes Progress With New Study Capricor Therapeutics, Inc., a clinical-stage biotechnology company, develops transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (DMD) and oth ...

We came across a bullish thesis on McDonald’s Corporation on wallstreetbets subreddit by nskidder. In this article, we will summarize the bulls’ thesis on MCD. McDonald’s Corporation's share was trading at $318.73 as of December 15th. MCD’s trailing and forward P/E were 27.02 and 23.92 respectively according to Yahoo Finance. People Love McDonald’s Corporation (MCD) Because Of Value, Says Jim Cramer McDonald's Corporation owns, operates, and franchises restaurants under the McDonald's brand in the United ...

We came across a bullish thesis on Moderna, Inc. on Alpha Talon Investment Research’s Substack by AT Investment Research. In this article, we will summarize the bulls’ thesis on MRNA. Moderna, Inc.'s share was trading at $29.92 as of December 15th. MRNA’s trailing P/E was 7.06 according to Yahoo Finance. Is Ultragenyx Pharmaceutical Inc. (RARE) One of the Best Biotech Stocks to Buy According to Wall Street Analysts? Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United St ...

We came across a bullish thesis on Sarepta Therapeutics, Inc. on Alpha Talon Investment Research’s Substack by AT Investment Research. In this article, we will summarize the bulls’ thesis on SRPT. Sarepta Therapeutics, Inc.'s share was trading at $21.55 as of December 15th. SRPT’s trailing and forward P/E were 169.47 and 17.39 respectively according to Yahoo Finance. Pixabay/Public Domain Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development o ...

We came across a bullish thesis on Viavi Solutions Inc. on Make Money, Make Time’s Substack by Oliver | MMMT Wealth. In this article, we will summarize the bulls’ thesis on VIAV. Viavi Solutions Inc.'s share was trading at $17.88 as of December 15th. VIAV’s trailing and forward P/E were 298.08 and 24.57 respectively according to Yahoo Finance. PureStorage (PSTG) Jumps as Earnings, Outlook Impress Viavi Solutions Inc. provides network test, monitoring, and assurance solutions for telecommunications, cloud ...

We came across a bullish thesis on Viking Therapeutics, Inc. on Alpha Talon Investment Research’s Substack by AT Investment Research. In this article, we will summarize the bulls’ thesis on VKTX. Viking Therapeutics, Inc.'s share was trading at $36.15 as of December 15th. Rio Tinto's CEO Announces Plan to Generate Up to $10 Billion Through Divestments & Other Strategies Copyright: dolgachov / 123RF Stock Photo Viking Therapeutics is a clinical-stage biotechnology company focused on metabolic and endocri ...

Welcome back. Stocks are higher after the cooler than expected inflation data this morning. But some questions now being raised about how much we might trust this print.Our Steve Leeman's looking into that. I'm seen the Brucellis response this morning. Uh [laughter] dude, that was one flawed report.>> That's one of my bullet points here, Carl. And you guys were just talking about this stocks loving this cooler than expected inflation report. The bond market and economists highly skeptical with many saying c ...

We came across a bullish thesis on Xeris Biopharma Holdings, Inc. on Alpha Talon Investment Research’s Substack by AT Investment Research and Rudy Does Research. In this article, we will summarize the bulls’ thesis on XERS. Xeris Biopharma Holdings, Inc.'s share was trading at $7.05 as of December 15th. XERS’s forward P/E was 64.10 according to Yahoo Finance. create jobs 51/Shutterstock.com Xeris Biopharma Holdings, Inc., a commercial-stage biopharmaceutical company, engages in developing and commercial ...